Toomaj Salehi risks being hanged after the conviction on the Shariah charge of "corruption on Earth" by a Revolutionary Court
Moderna said Thursday that protection from its Covid-19 vaccine remained strong for at least six months, and the variant-specific boosters shot it is testing generated a "robust" antibody response to Delta.
In a final analysis from its Phase 3, or final stage, clinical trial, Moderna's Covid vaccine showed 93 per cent efficacy at six months following the second dose.
The company is also carrying out clinical trials on three different Covid-19 boosters, with all of them producing high antibody levels against the original coronavirus strain and variants of concern, including Delta, originally identified in India.
"We are pleased that our Covid-19 vaccine is showing durable efficacy of 93% through six months, but recognize that the Delta variant is a significant new threat so we must remain vigilant," said CEO Stephane Bancel in a statement.
The statement added that Moderna expects to file its submission for full approval of its Covid vaccine with the US Food and Drug Administration this month.
The company has also begun studies for several other vaccines, including the flu, Zika, respiratory syncytial virus and others, and is developing a Covid vaccine that can be stored at fridge temperature.
Toomaj Salehi risks being hanged after the conviction on the Shariah charge of "corruption on Earth" by a Revolutionary Court
Aid groups warn any invasion would add to already-catastrophic conditions for Gaza's 2.4 million people
The American they will face Australia and Serbia on July 15 and July 17 as part of their preparation for the Paris Olympic Games
The leaders emphasise that the deal to release the hostages would bring an immediate and prolonged ceasefire in Gaza
Dubai-based Sumit Augustine has had a philosophical approach towards spending
The regional upswing also defies oil production cutbacks
It's a treatise that would determine the course of your life, not just academically, but as a person too
A US-based company is developing an eVTOL aircraft for commercial passenger service and is expected to start operations by 2025 or early 2026